The Annual Review of Biophysics, published by ANNUAL REVIEWS, stands as a premier journal in the field of biophysics, offering an unparalleled collection of comprehensive and insightful reviews that synthesize the latest advancements in biochemistry, bioengineering, cell biology, structural biology, and more. With an impressive Q1 ranking across multiple categories as of 2023, this journal is recognized for its significant contribution to the scientific community, highlighted by its robust Scopus ranking—placing it in the 99th percentile for biophysics and the 96th percentile for structural biology. Operating under an open access policy, the journal ensures a broad dissemination of crucial findings and theoretical advancements. As the field of biophysics continues to expand, the Annual Review of Biophysics remains essential for researchers, professionals, and students seeking to stay informed about pivotal developments that shape our understanding of biological systems at the molecular level. One may refer to the journal for current trends, innovative methodologies, and a wealth of knowledge that drives the field forward.

Molecular Therapy Nucleic Acids is a premier open-access journal published by CELL PRESS, dedicated to advancing the field of molecular medicine through the innovative application of nucleic acid-based therapies. Since its inception in 2012, this journal has become an essential resource for researchers and professionals in drug discovery and molecular medicine, reflected in its status as a Q1 journal in both categories for 2023. With a notable impact factor and high rankings in Scopus, including #8 out of 157 in Drug Discovery and #16 out of 178 in Molecular Medicine, it serves to disseminate groundbreaking research and foster collaborations among scientists worldwide. The journal's comprehensive scope encompasses a wide variety of topics, including gene therapy, RNA interference, and CRISPR technology, ensuring that it remains at the forefront of scientific excellence. With open access availability, Molecular Therapy Nucleic Acids actively promotes the widespread dissemination of knowledge, making its crucial insights accessible to students, researchers, and industry professionals alike.

PROSTAGLANDINS & OTHER LIPID MEDIATORS, published by Elsevier Science Inc, is a leading journal dedicated to the advancements in the field of lipid mediators, with a specific focus on prostaglandins and other bioactive lipids. This journal, indexed under ISSN 1098-8823 and E-ISSN 2212-196X, serves as a crucial platform for researchers and professionals to disseminate significant findings that span multiple disciplines, including Biochemistry, Cell Biology, Pharmacology, and Physiology. In the 2023 category quartiles, it has achieved commendable positions such as Q2 in Biochemistry and Q2 in Physiology, underscoring its importance and influence in these domains. Although it is not an open-access journal, it provides robust access options, enhancing the visibility of vital research. With its establishment in 1996, the journal continues its commitment to fostering innovative research until 2024, making it an essential resource for those involved in the dynamic realms of lipid biology and medical research.

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

Lipids in Health and Disease, published by BMC, stands as a leading open-access journal dedicated to advancing the understanding of lipid metabolism and its implications for health and disease. Since its inception in 2002, this journal has fostered accessibility to cutting-edge research, ensuring that knowledge in this vital field is disseminated widely to researchers, clinicians, and students worldwide. With a commendable Q1 ranking in multiple categories including Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, it appeals to a diverse readership, positioning itself at the forefront of research in biochemistry and medicine. It boasts an impressive Scopus rank, where it excels in areas such as Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, making it an essential resource for those looking to deepen their understanding of lipid biology and its clinical applications. Researchers can share and access findings that have significant implications for public health and disease prevention, emphasizing the journal's commitment to fostering innovation and collaboration in the scientific community.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

Current Opinion in Lipidology is a premier journal published by Lippincott Williams & Wilkins, offering critical insights into the ever-evolving landscape of lipid research. With an impressive convergence spanning from 1990 to 2024, this journal serves as an essential platform for researchers, clinicians, and professionals dedicated to the study of lipids in relation to cardiovascular health, endocrinology, and metabolism. The journal currently holds a distinguished Q1 ranking in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Nutrition and Dietetics, showcasing its significant impact in these fields. Additionally, it ranks in the Q2 quartile for Cell Biology and Molecular Biology, underlining its comprehensive approach to lipidology. Though not open access, the content is rich with cutting-edge reviews, clinical studies, and expert opinions that aim to advance knowledge and practice in lipid metabolism, making it a valuable resource for anyone seeking to stay abreast of the latest developments in lipid research.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

Biophysical Reports is an esteemed peer-reviewed journal published by Elsevier, dedicated to advancing the field of biophysics and related disciplines. Since its inception in 2021, this journal has rapidly gained recognition, achieving a Q1 ranking in Biophysics and Q2 rankings in both Biochemistry categories and Biotechnology as of 2023. The journal serves as a pivotal platform for disseminating innovative research findings and theoretical advancements, catering to a diverse readership that includes researchers, professionals, and students in the life sciences. With an ISSN of 2667-0747, Biophysical Reports aims to bridge the gap between molecular biochemistry and physical sciences, providing critical insights that contribute to the understanding of biomolecular processes. While offering no open-access options, it adheres to rigorous publication standards, ensuring high-quality content that reflects contemporary challenges and breakthroughs in biophysical research. For those engaged in the biosciences, this journal stands as an invaluable resource for exploring the intricacies of molecular interactions and the implications for biotechnology and genetic studies.